He obtained his MSc degree in Molecular & Genetic Medicine and finally awarded his Ph.D in Molecular Haematology from School of Medicine & Biomedical Sciences, University of Sheffield, United Kingdom in 2008. His research interest includes the pathogenesis of myeloid malignancies and the role of core binding factors proteins and receptor tyrosine kinases class III (RTKIII). His work involves mutational screening of RTK/RAS signalling pathways, and epigenetic screening of negative regulators. His current work is on development of drug resistant leukaemic cell lines and investigation of chemopreventive activities of natural products. He recently appointed as a secretariat in the Malaysian Node of Human Variome Project (MyHVP) and involves in the launch of South East Asia node of HVP.